Late Breaking Abstract - Therapeutic drug monitoring in a patient with very advanced XDR-TB
N. Köhler (Borstel, Germany), R. Aarnoutse (Nijmegen, Netherlands), P. Abel Zur Wiesch (Tromsø, Norway), S. Andres (Borstel, Germany), R. Bonomo (Cleveland, Ohio, United States of America), E. Choong (Lausanne, Switzerland), F. Clarelli (Tromsø, Norway), L. Decosterd (Lausanne, Switzerland), A. Dinardo (Houston, Texas, United States of America), H. Grobbel (Borstel, Germany), J. Heyckendorf (Borstel, Germany), D. Hillemann (Borstel, Germany), H. Hoffmann (Munich, Germany), B. Kalsdorf (Borstel, Germany), H. Karaköse (Borstel, Germany), W. Knaack (Borstel, Germany), C. König (Hamburg, Germany), A. Martinecz (Tromsø, Norway), F. Maurer (Borstel, Germany), M. Merker (Borstel, Germany), S. Niemann (Borstel, Germany), M. Nowak (Borstel, Germany), C. Peloquin (Gainesville, Florida, United States of America), P. Sanchez Carballo (Borstel, Germany), D. Schaub (Borstel, Germany), T. Schön (Linköping, Sweden), D. Schwudke (Borstel, Germany), M. Teulen (Nijmegen, Netherlands), N. Verougstraete (Ghent, Belgium), A. Verstraete (Ghent, Belgium), F. Waldow (Borstel, Germany), J. Werngren (Solna, Sweden), S. Wicha (Hamburg, Germany), C. Lange (Borstel, Germany)
Source: Virtual Congress 2021 – Challenges and advances in the diagnosis and clinical management of tuberculosis
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Köhler (Borstel, Germany), R. Aarnoutse (Nijmegen, Netherlands), P. Abel Zur Wiesch (Tromsø, Norway), S. Andres (Borstel, Germany), R. Bonomo (Cleveland, Ohio, United States of America), E. Choong (Lausanne, Switzerland), F. Clarelli (Tromsø, Norway), L. Decosterd (Lausanne, Switzerland), A. Dinardo (Houston, Texas, United States of America), H. Grobbel (Borstel, Germany), J. Heyckendorf (Borstel, Germany), D. Hillemann (Borstel, Germany), H. Hoffmann (Munich, Germany), B. Kalsdorf (Borstel, Germany), H. Karaköse (Borstel, Germany), W. Knaack (Borstel, Germany), C. König (Hamburg, Germany), A. Martinecz (Tromsø, Norway), F. Maurer (Borstel, Germany), M. Merker (Borstel, Germany), S. Niemann (Borstel, Germany), M. Nowak (Borstel, Germany), C. Peloquin (Gainesville, Florida, United States of America), P. Sanchez Carballo (Borstel, Germany), D. Schaub (Borstel, Germany), T. Schön (Linköping, Sweden), D. Schwudke (Borstel, Germany), M. Teulen (Nijmegen, Netherlands), N. Verougstraete (Ghent, Belgium), A. Verstraete (Ghent, Belgium), F. Waldow (Borstel, Germany), J. Werngren (Solna, Sweden), S. Wicha (Hamburg, Germany), C. Lange (Borstel, Germany). Late Breaking Abstract - Therapeutic drug monitoring in a patient with very advanced XDR-TB. 1054
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: